Clinical case of severe visceral complications with atypical localization in a patient with gout

Authors

DOI:

https://doi.org/10.26641/2307-0404.2023.1.276221

Keywords:

gout, blood uric acid, monosodium urate crystals

Abstract

The diagnosed gout is a signal to search for unrecognized concomitant conditions and their underlying causes and mechanisms of development. Due to the fact that gout is a common metabolic disorder with symptoms of localized inflammation caused by chronic and/or episodic deposition of monosodium urate crystals (MSU) in joints and soft tissues, the understanding of the inflammation interaction in metabolic disorders has changed. In cases of severe visceral complications of gout, the most common sites of tophl are kidneys, liver, spleen, lungs, pericardium, subcutaneous tissue and other soft tissues. The aim of this study was to outline the features of severe visceral complications with atypical localization in a patient with gout (identification of MSU crystals with polarization microscopy) and to determine the role of videothoracoscopy in this case. Patient N., 55 years old, complained of moderate chest pain, shortness of breath during exercise, general weakness and occasional cough. The patient was hospitalized in a multidisciplinary clinical institution. Examinations were performed, including polarization microscopy, spiral computed tomography (polytopic foci, formations), videothoracoscopy. Endoscopic resection of SVII of the lower lobe of the left lung with a biopsy of the lungs formations and mediastinal lymph nodes was performed. Results of histologic examination: amorphous masses are presented in combination with the organized chronic giant cell granulomatous structure (tophus), which contains clusters of crystals of MSU. Cytological examination of pleural cavity fluid revealed the presence of crystals of MSU. The presence of crystals of MSU was confirmed by polarization microscopy. From the anamnesis of the disease it became known that at the age of 38 the patient consulted a rheumatologist for moderate joint syndrome. On the basis of anamnesis, laboratory and instrumental data (X-ray, ultrasound examination) the diagnosis of gout, chronic gouty arthritis was established. Urate lowering therapy was prescribed. The patient took the drugs periodically without re-consultation with the doctor. The presented case of untreated gout has led to significant structural disorders in organs such as lungs, pleura. Endoscopic resection of the lower lobe of the left lung and revision of the thoracic cavity revealed atelectasis, hemorrhage, inflammatory infiltration, fibrous changes in tissues, amorphous masses with organized chronic giant cell granulomatous structure, presented by crystals of MSU. During the surgery, a powdery substance was found on the pleura surfaces. A video thoracoscopy in this case was a means to present a visceral damage in gout. The search for diagnostic tools to diagnose a severe visceral complications with atypical localization in gout still remains unsolved. Undoubtedly, the central role in the development of gout is played by the deposition of numerous crystals of MSU. In the patient under observation, crystals of MSU were found in pleural fluid and sputum consisting of sodium urate, like the known facts of their appearance in the joint fluid and urine. Uric acid salt crystals were also detected in the areas of pulmonary fibrosis formation according to the results of radiological examination, as well as endoscopic intervention in the lower lobe of the left lung.

References

Aiguo M, Jingyan W, Zhang Н, Dayong W. Analysis of Serum Ferritin and High Sensitive C Reactive Protein in Patients with Gout. FASEB J. 2017Jan.1;31(1):lb414. doi: https://doi.org/10.1096/fasebj.31.1_supplement.lb414

Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol. 2019;71(6):991-9. doi: https://doi.org/10.1002/art.40807

Fatima T, McKinney C, Major TJ, et al. The relationship between ferritin and urate levels and risk of gout. Arthritis Res Ther. 2018;20:179. doi: https://doi.org/10.1186/s13075-018-1668-y

Flais J, Bardou-Jacquet E, Deugnier Y, et al. Hyperferritinemia increases the risk of hyperuricemia in HFE-here¬ditary hemochromatosis. Joint Bone Spine. 2017;84(3):293-7. doi: https://doi.org/10.1016/j.jbspin.2016.05.020

Kondratjuk VJe, Tarasenko OM. [A modern look at the pathogenetic aspects of gout (literature review)]. Ukrainskyi revmatologichnyi zhurnal. 2018;74(4):32-7. Ukrainian.

Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843-55. doi: https://doi.org/10.1016/S0140-6736(21)00569-9

Choi HK, McCormick N, Yokose C. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol. 2022 Feb;18(2):97-111. doi: https://doi.org/10.1038/s41584-021-00725-9

Oda K, Kikuchi E, Kuroda E, et al. Uric acid, ferritin and γ-glutamyltransferase can be informative in prediction of the oxidative stress. J Clin Biochem Nutr. 2019;64(2):124-8. doi: https://doi.org/10.3164/jcbn.18-23

Ashiq K, Bajwa MA, Tanveer S, Qayyum M, Ashiq S, Khokhar R, Abid F. A comprehensive review on gout: The epidemiological trends, pathophysiology, clinical presentation, diagnosis and treatment. J Pak Med Assoc. 2021;71(4):1234-8. doi: https://doi.org/10.47391/JPMA.313

Singh JA, Joseph A, Baker J, Richman JS, Shaneyfelt T, Saag KG, et al. SToRytelling to Improve Disease outcomes in Gout (STRIDE-GO): a multicenter, randomized controlled trial in African American veterans with gout. BMC Med. 2021;19(1):265. doi: https://doi.org/10.1186/s12916-021-02135-w

Singh JA, Gaffo A. Gout epidemiology and co-morbidities. Semin Arthritis Rheum. 2020;50(3S):S11-S16. doi: https://doi.org/10.1016/j.semarthrit.2020.04.008

Klauser AS, Halpern EJ, Strobl S, Gruber J, Feuchtner G, Bellmann-Weiler R, et al. Dual-energy com-puted tomography detection of cardiovascular mono-sodium urate deposits in patients with gout. JAMA Cardiol. 2019;4:1019-28. doi: https://doi.org/10.1001/jamacardio.2019.3201

Khanna P, Johnson RJ, Marder B, LaMoreaux B, Kumar A. Systemic Urate Deposition: An Unrecognized Complication of Gout? J Clin Med. 2020;9(10):3204. doi: https://doi.org/10.3390/jcm9103204

Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31-8. doi: https://doi.org/10.1136/annrheumdis-2019-215315

Downloads

Published

2023-03-30

How to Cite

1.
Kuzmina G, Markova O, Lazarenko O. Clinical case of severe visceral complications with atypical localization in a patient with gout. Med. perspekt. [Internet]. 2023Mar.30 [cited 2024Apr.25];28(1):208-16. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/276221

Issue

Section

A CASE FROM PRACTICE